Abid oueslati
Université Laval
H-index: 21
North America-Canada
Top articles of Abid oueslati
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Corrigendum to" Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease"[Neurobiology of Disease, 2024 Jan: 190: 106376] | Neurobiology of disease | Stefan Bartl Yuanyun Xie Nalini Potluri Ratnesh Kesineni Katlin Hencak | 2024/2/23 |
Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease | Neurobiology of Disease | Stefan Bartl Yuanyun Xie Nalini Potluri Ratnesh Kesineni Katlin Hencak | 2024/1/1 |
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization | Cell Death & Disease | Olivier Lurette Rebeca Martín-Jiménez Mehtab Khan Razan Sheta Stéphanie Jean | 2023/11/10 |
Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons | STAR protocols | Razan Sheta Maxime Teixeira Walid Idi Abid Oueslati | 2023/9/15 |
Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson’s disease | STAR protocols | Maxime Teixeira Razan Sheta Walid Idi Abid Oueslati | 2023/12/15 |
Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains | Molecular Neurodegeneration | Morgan Bérard Laura Martínez-Drudis Razan Sheta Omar MA El-Agnaf Abid Oueslati | 2023/11/27 |
Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons | Scientific Reports | Razan Sheta Maxime Teixeira Walid Idi Marion Pierre Aurelie de Rus Jacquet | 2022/10/13 |
Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease | Neurobiology of Disease | Laura Martínez-Drudis Razan Sheta Rémi Pellegrinato Salma Loukili Cyntia Tremblay | 2022/10/1 |
A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease | Plos Biology | Morgan Bérard Razan Sheta Sarah Malvaut Raquel Rodriguez-Aller Maxime Teixeira | 2022/3/9 |
Alpha-Synuclein and the endolysosomal system in parkinson’s disease: guilty by association | Maxime Teixeira Razan Sheta Walid Idi Abid Oueslati | 2021/9 | |
I09 In vivo mtHTT protein reduction in the CNS and periphery by passive immunization with the monoclonal antibody C6–17 | Stefan Bartl Yuanyun Xie Nalini Potluri Benjamin Gordon Alicia Willenberg | 2021/9/1 | |
Shedding a new light on Huntington’s disease: How blood can both propagate and ameliorate disease pathology | Molecular psychiatry | Marie Rieux Melanie Alpaugh Giacomo Sciacca Martine Saint-Pierre Maria Masnata | 2021/9 |
Optogenetic-Mediated Spatiotemporal Control of α-Synuclein Aggregation Mimics Lewy Body Formation and Triggers Neurodegeneration | Morgan Berard Razan Sheta Sarah Malvaut Raquel Rodriguez-Aller Maxime Teixeira | 2021 | |
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates | Neurobiology of Disease | Philippe Gosset Alexander Maxan Melanie Alpaugh Ludivine Breger Benjamin Dehay | 2020/7/1 |
Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease | Stefan Bartl Abid Oueslati Amber L Southwell Alberto Siddu Michela Parth | 2020/7/1 | |
Light-inducible protein aggregation system for modeling proteinopathies and neurodegenerative disorders | 2020/1/9 | ||
Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates | Neurobiology of Disease | Alexander Maxan Giacomo Sciacca Melanie Alpaugh Zhu Tao Ludivine Breger | 2020/7/1 |